| Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing M Yadav, S Jhunjhunwala, QT Phung, P Lupardus, J Tanguay, ... Nature 515 (7528), 572-576, 2014 | 1372 | 2014 |
| Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion S Jhunjhunwala, C Hammer, L Delamarre Nature Reviews Cancer 21 (5), 298-312, 2021 | 1000 | 2021 |
| Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate L Delamarre, M Pack, H Chang, I Mellman, ES Trombetta Science 307 (5715), 1630-1634, 2005 | 975 | 2005 |
| Peripheral T cell expansion predicts tumour infiltration and clinical response TD Wu, S Madireddi, PE de Almeida, R Banchereau, YJJ Chen, AS Chitre, ... Nature 579 (7798), 274-278, 2020 | 617 | 2020 |
| Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination JS Shin, M Ebersold, M Pypaert, L Delamarre, A Hartley, I Mellman Nature 444 (7115), 115-118, 2006 | 349 | 2006 |
| Mature dendritic cells use endocytic receptors to capture and present antigens CD Platt, JK Ma, C Chalouni, M Ebersold, H Bou-Reslan, RAD Carano, ... Proceedings of the National Academy of Sciences 107 (9), 4287-4292, 2010 | 342 | 2010 |
| IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines S Tahtinen, AJ Tong, P Himmels, J Oh, A Paler-Martinez, L Kim, ... Nature immunology 23 (4), 532-542, 2022 | 330 | 2022 |
| Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation L Delamarre, H Holcombe, I Mellman The Journal of experimental medicine 198 (1), 111-122, 2003 | 316 | 2003 |
| Endosomes are specialized platforms for bacterial sensing and NOD2 signalling N Nakamura, JR Lill, Q Phung, Z Jiang, C Bakalarski, A de Maziere, ... Nature 509 (7499), 240-244, 2014 | 310 | 2014 |
| Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation B Vander Lugt, AA Khan, JA Hackney, S Agrawal, J Lesch, M Zhou, ... Nature immunology 15 (2), 161-167, 2014 | 303 | 2014 |
| Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell … C Berlioz-Torrent, BL Shacklett, L Erdtmann, L Delamarre, I Bouchaert, ... Journal of virology 73 (2), 1350-1361, 1999 | 251 | 1999 |
| Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis L Delamarre, R Couture, I Mellman, ES Trombetta The Journal of experimental medicine 203 (9), 2049-2055, 2006 | 249 | 2006 |
| Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells B Chatterjee, A Smed-Sörensen, L Cohn, C Chalouni, R Vandlen, BC Lee, ... Blood, The Journal of the American Society of Hematology 120 (10), 2011-2020, 2012 | 243 | 2012 |
| Dendritic cell-targeted vaccines L Cohn, L Delamarre Frontiers in immunology 5, 255, 2014 | 234 | 2014 |
| Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation L Cohn, B Chatterjee, F Esselborn, A Smed-Sörensen, N Nakamura, ... Journal of Experimental Medicine 210 (5), 1049-1063, 2013 | 233 | 2013 |
| Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells A Smed-Sörensen, C Chalouni, B Chatterjee, L Cohn, P Blattmann, ... PLoS pathogens 8 (3), e1002572, 2012 | 120 | 2012 |
| A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity L Delamarre, AR Rosenberg, C Pique, D Pham, MC Dokhélar Journal of Virology 71 (1), 259-266, 1997 | 112 | 1997 |
| Mutation position is an important determinant for predicting cancer neoantigens AH Capietto, S Jhunjhunwala, SB Pollock, P Lupardus, J Wong, L Hänsch, ... Journal of Experimental Medicine 217 (4), 2020 | 93 | 2020 |
| Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9 EC Freund, JY Lock, J Oh, T Maculins, L Delamarre, CJ Bohlen, B Haley, ... Journal of Experimental Medicine 217 (7), e20191692, 2020 | 82 | 2020 |
| Harnessing dendritic cells for immunotherapy L Delamarre, I Mellman Seminars in immunology 23 (1), 2-11, 2011 | 78 | 2011 |